SCHEMBL8103321

SCHEMBL8103321

C[n+]1ccccc1C=C(c1ccccc1)N1CCOCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.41
PHGDH O43175 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.40
GAA P10253 1/20 0.40
ACHE P22303 2/20 0.40
HRH1 P35367 1/20 0.40
PDE4D Q08499 1/20 0.40
FAAH O00519 1/20 0.39
MGLL Q99685 1/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
AKR1C3 P42330 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 3/20 0.39
RAB9A P51151 3/20 0.39
ALDH1A1 P00352 2/20 0.39
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8103317 1.00 TSHR (0.41) TSHRPHGDHHPGDSMN1; SMN2GAA
Iodide SCHEMBL5949586 0.99 SMN1; SMN2 (0.41) TSHRPHGDHHPGDSMN1; SMN2GAA
Iodide SCHEMBL5949583 0.99 SMN1; SMN2 (0.41) TSHRPHGDHHPGDSMN1; SMN2GAA
SCHEMBL6344962 0.91 PHGDH (0.38) TSHRPHGDHHPGDSMN1; SMN2GAA
SCHEMBL8103467 0.87 ACHE (0.42) TSHRHPGDSMN1; SMN2GAAACHE
SCHEMBL8103469 0.87 ACHE (0.42) TSHRHPGDSMN1; SMN2GAAACHE
Iodide SCHEMBL5948720 0.86 KDM4E (0.44) TSHRHPGDSMN1; SMN2GAAACHE
Iodide SCHEMBL5948723 0.86 KDM4E (0.44) TSHRHPGDSMN1; SMN2GAAACHE
SCHEMBL8103390 0.79 MAPT (0.38) TSHRPHGDHHPGDSMN1; SMN2GAA
SCHEMBL8103388 0.79 MAPT (0.38) TSHRPHGDHHPGDSMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1050531-A1 Pyridine and piperidine derivatives for treating neurodegenerative diseases ADIR ET COMPAGNIE (FR) 2000-11-08 EP disclosed